Nieto, J., Strohbehn, G., Goldstein, D. A., Bryant, A. (2026). Comparative effectiveness of pembrolizumab and nivolumab as first-line treatment for advanced/unresectable or metastatic melanoma: A propensity-score adjusted analysis from a US national health system.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e21513